医学
血管生成
伤口愈合
祖细胞
内皮祖细胞
脐静脉
脐带
免疫学
干细胞
男科
药理学
癌症研究
细胞生物学
体外
生物
生物化学
作者
Nan‐Chieh Huang,Lien‐Guo Dai,Lan-Ya Kang,Nien-Chi Huang,Keng‐Yen Fu,Pai‐Shan Hsieh,Niann‐Tzyy Dai
出处
期刊:Annals of Plastic Surgery
[Ovid Technologies (Wolters Kluwer)]
日期:2021-02-01
卷期号:86 (2S): S3-S12
被引量:7
标识
DOI:10.1097/sap.0000000000002655
摘要
Astragaloside IV (AS-IV) is a natural herb extract and a popular compound used in traditional Chinese medicine because of its effect on multiple biological processes, such as promotion of cell proliferation, improvement in cardiopulmonary and vascular function, and promotion of angiogenesis around wounds, leading to accelerated wound healing. Vascular regeneration primarily results from the differentiation of endothelial progenitor cells (EPCs). Biomedical acceleration of angiogenesis and differentiation of EPCs around the wound remain challenging.In this study, we treated human umbilical cord blood-derived EPCs with AS-IV and cultured them on 2-dimensional (tissue culture polystyrene) and 3-dimensional culture plates (3DPs). These cultured cells were then combined with human blood plasma gel and applied on the skin of nude mice in an attempt to repair full-thickness skin defects.The results show that using 3DP culture could increase vascular-related gene expression in EPCs. Furthermore, 12.5 μg/mL AS-IV-treaded EPCs were combined with plasma gels (P-3DP-EPC12.5) and showed enhanced vascular-related protein expression levels after 3 days of culture. Finally, P-3DP-EPC12.5s were used to repair full-thickness skin defects in nude mice, and we could register a wound healing rate greater than 90% by day 14.Based on these results, we concluded that we have developed a potential therapeutic approach for wound healing using plasma gel containing 3-dimensional surface-cultured AS-IV-treated EPCs.
科研通智能强力驱动
Strongly Powered by AbleSci AI